Osel is a developer of live biotherapeutic products that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. Its approach identifies differences between healthy and disease-related microbiomes and leverages beneficial microbes to treat problematic disruptions. The company focuses on women’s health and disorders of the gastrointestinal tract.